SQ-Kyrin-T First-in-man Feasibility Study

The goal of this clinical trial is to evaluate the performance, operability and reliability of the SQ-Kyrin-T Transcatheter Edge-to Edge Valve Repair System in treating severe tricuspid regurgitation in Chinese population with high or prohibitive risk for conventional surgery; and to provide safety and efficacy data on which subsequent confirmatory trial can be based.

NCT Number	NCT06605313
Lead Sponsor	Shanghai Shenqi Medical Technology Co., Ltd
Conditions	Tricuspid Regurgitation
Enrollment	12 participants
Start Date	2022-06-16
Primary Completion	2022-12-07 (estimated)
Study Completion	2027-11-24 (estimated)
Updated on ClinicalTrials.gov	2024-09-20